Paper8094768
Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion.
Goldhaber SZ and 9 others. Lancet, 1993. Cited by 671 papers, by iCite.
Cite this record
ConductScience Library. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Papers, record 8094768. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8094768
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heparin | Major topic |
| Pulmonary Circulation | Major topic |
| Pulmonary Embolism | Major topic |
| Tissue Plasminogen Activator | Major topic |
| Ventricular Function, Left | Major topic |
| Acute Disease | |
| Aged | |
| Echocardiography | |
| Female | |
| Humans | |
| Lung | |
| Male | |
| Middle Aged | |
| Radionuclide Imaging | |
| Thrombolytic Therapy |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02268903 | Diuretic Versus Placebo in Pulmonary Embolism | Background |
Source ClinicalTrials.gov
Cited by149
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 671 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42358640 | Evolution of advanced revascularization strategies for high-risk pulmonary embolism: a physiology-guided single-center experience. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42358640 | PubMed |
| 42315722 | Robustness and fragility of evidence supporting systemic thrombolysis in acute pulmonary embolism. | J Thromb Thrombolysis | 2026 | https://conductscience.org/library/papers/42315722 | PubMed |
| 42170188 | Thrombolysis for pulmonary embolism: A network meta-analysis. | J Intensive Care Soc | 2026 | https://conductscience.org/library/papers/42170188 | PubMed |
| 41984155 | Mechanical thrombectomy improves left ventricular filling in intermediate-high risk pulmonary embolism: the role of ventricular interdependence. | Clin Res Cardiol | 2026 | https://conductscience.org/library/papers/41984155 | PubMed |
| 40961960 | Prospective Multicenter IDE Study of the Next-Generation Precision Aspiration Thrombectomy System for Intermediate-Risk Pulmonary Embolism: The SYMPHONY-PE Trial. | Circ Cardiovasc Interv | 2025 | https://conductscience.org/library/papers/40961960 | PubMed |
| 40943975 | Intermediate-Risk Pulmonary Embolism: Patients' Stratification, Prognosis, and Therapeutic Options-Time to Pay Attention to the Middle Child. | J Clin Med | 2025 | https://conductscience.org/library/papers/40943975 | PubMed |
| 40903476 | Mendelian randomization analysis of the association between vitamin B12 deficiency anaemia and the risk of developing lung disease. | Sci Rep | 2025 | https://conductscience.org/library/papers/40903476 | PubMed |
| 40761678 | Acute Compartment Syndrome Post-Thrombolysis for Acute Pulmonary Embolism-A Case Report. | Clin Case Rep | 2025 | https://conductscience.org/library/papers/40761678 | PubMed |
| 40531728 | Brazilian guidelines for the pharmacological treatment of pulmonary embolism. Official document of the Brazilian Thoracic Association based on the GRADE methodology. | J Bras Pneumol | 2025 | https://conductscience.org/library/papers/40531728 | PubMed |
| 40525417 | The use of Veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO) for Acute High Risk Pulmonary Embolism: A Systematic Review. | Curr Cardiol Rev | 2025 | https://conductscience.org/library/papers/40525417 | PubMed |
| 40061412 | Novel Mechanical Aspiration Thrombectomy in Patients With Acute Pulmonary Embolism: Results From the Prospective APEX-AV Trial. | J Soc Cardiovasc Angiogr Interv | 2025 | https://conductscience.org/library/papers/40061412 | PubMed |
| 39825435 | Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis. | Thromb J | 2025 | https://conductscience.org/library/papers/39825435 | PubMed |
| 39768560 | A Practical Clinical Approach to Navigate Pulmonary Embolism Management: A Primer and Narrative Review of the Evolving Landscape. | J Clin Med | 2024 | https://conductscience.org/library/papers/39768560 | PubMed |
| 39638275 | Rationale and design of the PE-TRACT trial: A multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolism. | Am Heart J | 2025 | https://conductscience.org/library/papers/39638275 | PubMed |
| 39267429 | Anticoagulant Impact on Clinical Outcomes of Pulmonary Embolism Compared With Thrombolytic Therapy; Meta-Analysis. | Clin Cardiol | 2024 | https://conductscience.org/library/papers/39267429 | PubMed |
| 39215952 | Acute Pulmonary Embolism: Evidence, Innovation, and Horizons. | Curr Cardiol Rep | 2024 | https://conductscience.org/library/papers/39215952 | PubMed |
| 39156451 | Sub-massive Pulmonary Embolism and New-Onset Diabetes Mellitus. | Cureus | 2024 | https://conductscience.org/library/papers/39156451 | PubMed |
| 39076909 | Obstructive Shock, from Diagnosis to Treatment. | Rev Cardiovasc Med | 2022 | https://conductscience.org/library/papers/39076909 | PubMed |
| 38767729 | Endovascular treatments of acute pulmonary embolism in the post-fibrinolytic era: an up-to-date review. | Insights Imaging | 2024 | https://conductscience.org/library/papers/38767729 | PubMed |
| 38112771 | High and intermediate risk pulmonary embolism in the ICU. | Intensive Care Med | 2024 | https://conductscience.org/library/papers/38112771 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8094768
GET https://conductscience.org/api/papers/v1/8094768/cited_by?page=2